152 related articles for article (PubMed ID: 26183972)
1. The new US Food and Drug Administration pregnancy and lactation labeling rules: Their impact on clinical practice.
Danesh MJ; Murase JE
J Am Acad Dermatol; 2015 Aug; 73(2):310-1. PubMed ID: 26183972
[No Abstract] [Full Text] [Related]
2. Prescribing black box drugs: how to watch for liability traps.
Knothe BD
Med Econ; 2013 Dec; 90(24):56. PubMed ID: 25211812
[No Abstract] [Full Text] [Related]
3. Recent changes in pregnancy and lactation labeling: retirement of risk categories.
Ramoz LL; Patel-Shori NM
Pharmacotherapy; 2014; 34(4):389-95. PubMed ID: 24390829
[TBL] [Abstract][Full Text] [Related]
4. Uses of drugs not described in the package insert (off-label uses).
Committee on Drugs. American Academy of Pediatrics
Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Pregnancy and Lactation Labeling Rule (PLLR) on Practicing Dermatologists.
Beroukhim K; Abrouk M; Farahnik B
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632938
[TBL] [Abstract][Full Text] [Related]
6. Preterm births, multiples, and fertility treatment: recommendations for changes to policy and clinical practices.
Johnston J; Gusmano MK; Patrizio P
Fertil Steril; 2014 Jul; 102(1):36-9. PubMed ID: 24739454
[No Abstract] [Full Text] [Related]
7. Understanding the new pregnancy and lactation drug labeling.
Watkins EJ; Archambault M
JAAPA; 2016 Feb; 29(2):50-2. PubMed ID: 26818647
[TBL] [Abstract][Full Text] [Related]
8. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2014 Dec; 79(233):72063-103. PubMed ID: 25509060
[TBL] [Abstract][Full Text] [Related]
9. Are "off-labels" legal?
Price EC
Mich Health Hosp; 1998; 34(6):20-1. PubMed ID: 10187136
[TBL] [Abstract][Full Text] [Related]
10. Canada removes ban on physician-assisted suicide.
Burki TK
Lancet Oncol; 2015 Mar; 16(3):e110. PubMed ID: 25683850
[No Abstract] [Full Text] [Related]
11. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Brucker MC; King TL
J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
[TBL] [Abstract][Full Text] [Related]
12. FDA Implements New Labeling for Medications Used During Pregnancy and Lactation.
Whyte J
Am Fam Physician; 2016 Jul; 94(1):12-5. PubMed ID: 27386718
[No Abstract] [Full Text] [Related]
13. Medication use in pregnancy and the pregnancy and lactation labeling rule.
Sahin L; Nallani SC; Tassinari MS
Clin Pharmacol Ther; 2016 Jul; 100(1):23-5. PubMed ID: 27082701
[TBL] [Abstract][Full Text] [Related]
14. Off-label prescribing of medications for pain: maintaining optimal care at an intersection of law, public policy, and ethics.
Ruble J
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):146-52. PubMed ID: 22764854
[TBL] [Abstract][Full Text] [Related]
15. Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug products.
Tassinari MS; Sahin L; Yao LP
Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):718-20. PubMed ID: 26223007
[TBL] [Abstract][Full Text] [Related]
16. FDA drug labeling for pregnancy and lactation drug safety monitoring systems.
Greene MF
Semin Perinatol; 2015 Nov; 39(7):520-3. PubMed ID: 26428020
[TBL] [Abstract][Full Text] [Related]
17. How your practice can cope with change.
Beck LC; Anders GT; Sweeney DR
Ariz Med; 1985 Apr; 42(4):236-9. PubMed ID: 2980751
[No Abstract] [Full Text] [Related]
18. Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs.
Fantasia HC; Harris AL
Nurs Womens Health; 2015; 19(3):266-70. PubMed ID: 26058910
[TBL] [Abstract][Full Text] [Related]
19. The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources.
Harris JB; Holmes AP; Eiland LS
Ann Pharmacother; 2021 Apr; 55(4):459-465. PubMed ID: 32885981
[TBL] [Abstract][Full Text] [Related]
20. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
Poser S
Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
